Heidi Glosli

  • Overlege, barnelege; Phd
  • 23 07 45 93
 

Original articles

Terwisscha van Scheltinga SEJ, Wijnen MHWA, Martelli H, Rogers T, Mandeville H, Gaze MN, McHugh K, Corradini N, Orbach D, Jenney M, Kelsey A, Chisholm J, Gallego S, Glosli H, Ferrari A, Zanetti I, De Salvo GL, Minard-Colin V, Bisogno G, van Noesel MM, Merks HHM (2020)
Local staging and treatment in extremity rhabdomyosarcoma. A report from the EpSSG-RMS2005 study
Cancer Med, 9 (20), 7580-7589
DOI 10.1002/cam4.3365, PubMed 32869534

Skjefstad K, Solberg O, Glosli H, von der Lippe C, Feragen KB (2020)
Life expectancy and cause of death in individuals with haemophilia A and B in Norway, 1986-2018
Eur J Haematol, 105 (5), 608-615
DOI 10.1111/ejh.13494, PubMed 32710483

Bisogno G, De Salvo GL, Bergeron C, Gallego Melcón S, Merks JH, Kelsey A, Martelli H, Minard-Colin V, Orbach D, Glosli H, Chisholm J, Casanova M, Zanetti I, Devalck C, Ben-Arush M, Mudry P, Ferman S, Jenney M, Ferrari A, European paediatric Soft tissue sarcoma Study Group (2019)
Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial
Lancet Oncol, 20 (11), 1566-1575
DOI 10.1016/S1470-2045(19)30617-5, PubMed 31562043

Skou AS, Olsen SØ, Nielsen LH, Glosli H, Jahnukainen K, Jarfelt M, Jónmundsson GK, Malmros J, Nysom K, Hasle H, Nordic Society of Pediatric Hematology and Oncology (NOPHO) (2019)
Hearing Status in Survivors of Childhood Acute Myeloid Leukemia Treated With Chemotherapy Only: A NOPHO-AML Study
J Pediatr Hematol Oncol, 41 (1), e12-e17
DOI 10.1097/MPH.0000000000001302, PubMed 30550508

Wilhelmsson M, Glosli H, Ifversen M, Abrahamsson J, Winiarski J, Jahnukainen K, Hasle H, Nordic Society of Pediatric Hematology and Oncology (NOPHO) (2018)
Long-term health outcomes in survivors of childhood AML treated with allogeneic HSCT: a NOPHO-AML Study
Bone Marrow Transplant, 54 (5), 726-736
DOI 10.1038/s41409-018-0337-8, PubMed 30242226

Bisogno G, Jenney M, Bergeron C, Gallego Melcón S, Ferrari A, Oberlin O, Carli M, Stevens M, Kelsey A, De Paoli A, Gaze MN, Martelli H, Devalck C, Merks JH, Ben-Arush M, Glosli H, Chisholm J, Orbach D, Minard-Colin V, De Salvo GL, European paediatric Soft tissue sarcoma Study Group (2018)
Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial
Lancet Oncol, 19 (8), 1061-1071
DOI 10.1016/S1470-2045(18)30337-1, PubMed 29941280

Gallego S, Zanetti I, Orbach D, Ranchère D, Shipley J, Zin A, Bergeron C, de Salvo GL, Chisholm J, Ferrari A, Jenney M, Mandeville HC, Rogers T, Merks JHM, Mudry P, Glosli H, Milano GM, Ferman S, Bisogno G, European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) (2018)
Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)
Cancer, 124 (15), 3201-3209
DOI 10.1002/cncr.31553, PubMed 29797665

Vaarwerk B, van der Lee JH, Breunis WB, Orbach D, Chisholm JC, Cozic N, Jenney M, van Rijn RR, McHugh K, Gallego S, Glosli H, Devalck C, Gaze MN, Kelsey A, Bergeron C, Stevens MCG, Oberlin O, Minard-Colin V, Merks JHM (2017)
Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 study
Cancer, 124 (5), 1016-1024
DOI 10.1002/cncr.31157, PubMed 29211298

Zeller B, Glosli H, Forestier E, Ha SY, Jahnukainen K, Jónsson ÓG, Lausen B, Palle J, Hasle H, Abrahamsson J, NOPHO AML working group (2017)
Hyperleucocytosis in paediatric acute myeloid leukaemia - the challenge of white blood cell counts above 200 × 109 /l. The NOPHO experience 1984-2014
Br J Haematol, 178 (3), 448-456
DOI 10.1111/bjh.14692, PubMed 28542715

Ferrari A, Trama A, De Paoli A, Bergeron C, Merks JHM, Jenney M, Orbach D, Chisholm JC, Gallego S, Glosli H, De Salvo GL, Botta L, Gatta G, Bisogno G, RARECAREnet Working Group (2016)
Access to clinical trials for adolescents with soft tissue sarcomas: Enrollment in European pediatric Soft tissue sarcoma Study Group (EpSSG) protocols
Pediatr Blood Cancer, 64 (6)
DOI 10.1002/pbc.26348, PubMed 27882658

Jarfelt M, Andersen NH, Glosli H, Jahnukainen K, Jónmundsson GK, Malmros J, Nysom K, Hasle H, Nordic Society of Pediatric Hematology and Oncology (NOPHO) (2015)
Cardiac function in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study
Eur J Haematol, 97 (1), 55-62
DOI 10.1111/ejh.12683, PubMed 26383901

Skou AS, Glosli H, Jahnukainen K, Jarfelt M, Jónmundsson GK, Malmros-Svennilson J, Nysom K, Hasle H, Nordic Society of Pediatric Hematology and Oncology (2014)
Renal, gastrointestinal, and hepatic late effects in survivors of childhood acute myeloid leukemia treated with chemotherapy only--a NOPHO-AML study
Pediatr Blood Cancer, 61 (9), 1638-43
DOI 10.1002/pbc.25069, PubMed 24760750

Molgaard-Hansen L, Skou AS, Juul A, Glosli H, Jahnukainen K, Jarfelt M, Jónmundsson GK, Malmros J, Nysom K, Hasle H, Nordic Society of Pediatric Hematology and Oncology (2013)
Pubertal development and fertility in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study
Pediatr Blood Cancer, 60 (12), 1988-95
DOI 10.1002/pbc.24715, PubMed 24038890

Molgaard-Hansen L, Möttönen M, Glosli H, Jónmundsson GK, Abrahamsson J, Hasle H, Nordic Society of Paediatric Haematology and Oncology (NOPHO) (2011)
Treatment-related deaths in second complete remission in childhood acute myeloid leukaemia
Br J Haematol, 152 (5), 623-30
DOI 10.1111/j.1365-2141.2010.08554.x, PubMed 21241281

Molgaard-Hansen L, Glosli H, Jahnukainen K, Jarfelt M, Jónmundsson GK, Malmros-Svennilson J, Nysom K, Hasle H, Nordic Society of Pediatric Hematology and Oncology (2010)
Quality of health in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study
Pediatr Blood Cancer, 57 (7), 1222-9
DOI 10.1002/pbc.22931, PubMed 22095929

Molgaard-Hansen L, Möttönen M, Glosli H, Jónmundsson GK, Abrahamsson J, Hasle H, Nordic Society of Paediatric Haematology and Oncology (NOPHO) (2010)
Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003
Br J Haematol, 151 (5), 447-59
DOI 10.1111/j.1365-2141.2010.08389.x, PubMed 20955398

Glosli H, Stray-Pedersen A, Brun AC, Holtmon LW, Tønjum T, Chapgier A, Casanova JL, Abrahamsen TG (2008)
Infections due to various atypical mycobacteria in a Norwegian multiplex family with dominant interferon-gamma receptor deficiency
Clin Infect Dis, 46 (3), e23-7
DOI 10.1086/525855, PubMed 18171304

Glosli H, Gudbrandsen OA, Mullen AJ, Halvorsen B, Røst TH, Wergedahl H, Prydz H, Aukrust P, Berge RK (2005)
Down-regulated expression of PPARalpha target genes, reduced fatty acid oxidation and altered fatty acid composition in the liver of mice transgenic for hTNFalpha
Biochim Biophys Acta, 1734 (3), 235-46
DOI 10.1016/j.bbalip.2005.02.011, PubMed 15893958

Glosli H, Prydz H, Roald B (2004)
Involution of thymus and lymphoid depletion in mice expressing the hTNF transgene
APMIS, 112 (1), 63-73
DOI 10.1111/j.1600-0463.2004.apm1120111.x, PubMed 14961977

Glosli H, Tronstad KJ, Wergedal H, Müller F, Svardal A, Aukrust P, Berge RK, Prydz H (2002)
Human TNF-alpha in transgenic mice induces differential changes in redox status and glutathione-regulating enzymes
FASEB J, 16 (11), 1450-2
DOI 10.1096/fj.01-0948fje, PubMed 12205044

Glosli H, Veiby OP, Fjerdingstad H, Mehlum A, Probert L, Kollias G, Gjernes E, Prydz H (1999)
Effects of hTNFalpha expression in T cells on haematopoiesis in transgenic mice
Eur J Haematol, 63 (1), 50-60
DOI 10.1111/j.1600-0609.1999.tb01850.x, PubMed 10414455

Dahl-Jørgensen K, Glosli H, Joner G, Rønningen KS, Søvik O (1992)
[Can type 1 diabetes be prevented?]
Tidsskr Nor Laegeforen, 112 (23), 2951-2
PubMed 1412340

Other articles

Naumburg E, Rane A, Halvorsen T, Glosli H, Henriksen TB, Haraldsson À, Kallio J, Lepola P (2019)
Tardy development of safe medicines for children: a Nordic network offers new platform to reduce this inequity
Acta Paediatr, 108 (6), 992-993
DOI 10.1111/apa.14775, PubMed 30844088

Theses

Glosli H (2003)
Pleiotropic effects of low, persistent expression of human TNF in transgenic mice
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 138, 1 b. (flere pag.)
BIBSYS 032121024, ISBN 82-8072-096-0

Page visits: 3129